Basic and clinical study for the pathogenesis of malignant clone of mantle cell lymphoma

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900028386

Enrollment

Unknown

Registered

2019-12-20

Start date

2020-01-30

Completion date

Unknown

Last updated

2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mantle Cell Lymphoma

Interventions

patients with mantle cell lymphoma group vs. healthy concotrol group:Nil

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: The diagnosed cases of mantle cell lymphoma with stage III-IV and healthy donors.

Exclusion criteria

Exclusion criteria: The patients with other hematologic diseases, tumors of other systems and severe infections.

Design outcomes

Primary

Measure	Time frame
Immunophenotype;Genomics;	—

Countries

China

Contacts

Public ContactTang Junling

Department of Hematology, the Affiliated Hospital of Southwest Medical University

61484355@qq.com+86 13320789626

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026